Veranova

Name

Veranova

Legal name

Veranova Parent Holdco, L.P.

Website

https://veranova.com

Company type

Private

Founded year

1780

Operating status

Operating

Headcount range

501–1,000 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical API Contract Development and Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412), Scientific Research and Development Services (5417)

SIC

Medicinal Chemicals & Botanical Products (2833), Services-Commercial Physical & Biological Research (8731), Pharmaceutical Preparations (2834)

akta.pro primary industry

Small-Molecule API & Intermediates CDMO (HLAGABAA)

akta.pro secondary industries

Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB), Drug Substance–Drug Product Integrated CDMO (HLAGABAG)

Keywords

• Contract API development
• Pharmaceutical manufacturing services
• Highly potent API manufacturing
• Antibody-drug conjugate CDMO
• Controlled substance manufacturing

Headquarters

HQ city

Wayne

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Custom API Development and Manufacturing Services: Fee-for-service CDMO model providing pharmaceutical companies with development and manufacturing services for active pharmaceutical ingredients. Services span from early-phase development through commercial manufacturing, with integrated project management and regulatory support. Revenue is generated through project-based contracts, scale-up fees, and manufacturing runs based on customer requirements.
2. Generic API Products: Sale of generic active pharmaceutical ingredients including controlled substances. Portfolio includes APIs, reference standards, and controlled substance products. Revenue generated through product sales to pharmaceutical manufacturers.
3. Solid Form and Particle Engineering Services: Specialized development services including crystallization development, amorphous solid dispersion, spray drying, polymorph screening, and particle size modification. Revenue generated through service contracts and project-based engagements.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

Veranova is a global Contract Development and Manufacturing Organization (CDMO) providing integrated development and manufacturing services for complex and highly potent active pharmaceutical ingredients (APIs). The company offers end-to-end capabilities spanning early-phase process and analytical development, solid form and particle engineering, custom API manufacturing at clinical and commercial scales, specialty modalities such as ADCs and TIDES, and licensed controlled substance manufacturing for pharmaceutical and biotech customers across the US and UK.

Product overview

Veranova is a global CDMO (Contract Development and Manufacturing Organization) providing integrated services across the pharmaceutical drug substance lifecycle. The company's unified platform encompasses CDMO Services as its core offering, with specialized sub-products including Solid Form & Particle Engineering (featuring Amorphous Solid Dispersion, Crystallization Development, Spray Drying, and Structure Confirmation via SCXRD), Process and Analytical Development, Custom API Manufacturing (with Highly Potent APIs and Controlled Substance Manufacturing), and Specialty Modalities (covering ADCs with Linkers/Payloads/Conjugates, PROTACs, PEGs and Lipids, and TIDES). The company also offers Generic API Products and operates the Pharmorphix® Solid State Services brand for specialized solid form sciences. A notable consumer product is Bitrex®, a bittering agent for child safety. Veranova serves pharmaceutical and biotech customers from GMP-certified facilities in the US and UK, supporting innovation from early-phase development through commercial-scale manufacturing.

Differentiator

Problem solved

Functional benefit

Brands

• Pharmorphix: Solid state services brand offering single crystal X-ray diffraction and solid form science expertise for early drug development.

Products and services

• CDMO Services Contract Development and Manufacturing Organization services spanning the full drug substance lifecycle from early development through commercial manufacturing. Targets pharmaceutical and biotech companies requiring external development and manufacturing partners for complex APIs.
• Solid Form & Particle Engineering Comprehensive solid form sciences including crystallization development, particle engineering, polymorph screening, salt and cocrystal screening, amorphous solid dispersion, and spray drying services. Used by pharmaceutical developers to optimize bioavailability and select optimal solid forms.
• Process and Analytical Development Phase-appropriate process development and analytical method development services including separations and purifications, technology transfer, and quality and regulatory affairs. Supports drug development lifecycle compliance with ICH, FDA, MHRA, and EMEA requirements.
• Custom API Manufacturing End-to-end custom active pharmaceutical ingredient manufacturing including multi-scale clinical and commercial API production. Includes complex small molecules, highly potent APIs, and Schedule I-V controlled substances under cGMP conditions.
• Specialty Modalities Specialized capabilities including antibody-drug conjugates (linkers, payloads, and conjugates), PEGs and lipids, PROTACs, and TIDES (nucleotides, oligonucleotides, and peptides). Targeted at novel therapeutic modalities.
• Generic API Products Portfolio of generic active pharmaceutical ingredients and controlled substances with reference standards and API life cycle management support. Sold to generic pharmaceutical manufacturers for formulation use.
• Bitrex The world's most bitter substance known, used as a safety component to make potentially harmful household, personal care, autocare, and pesticide products unpalatable and prevent accidental poisoning, especially in children. Licensed to partners such as Nutriband.
• Pharmorphix Solid State Services Specialized solid form sciences sub-brand providing polymorph screening, salt selection, crystallization development, cocrystal screening, and single crystal X-ray diffraction (SCXRD) services for early drug development customers.

Quantifiable outcome

• 18% of FDA-approved small molecule drugs since 2014 have collaborated with Veranova
• +4 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Nine partnerships are on record, tiered minor.

• APIC (Active Pharmaceutical Ingredients Committee)minorOthers · 14 October 2025APIC is a sector group within Cefic (European Chemical Industry Council) focusing on worldwide GMP and regulatory matters relating to APIs and intermediates. Veranova is a member company, participating in industry advocacy and regulatory discussions.
• BPTF (Bulk Pharmaceutical Task Force)minorOthers · 14 October 2025US industry trade organization representing manufacturers of APIs, intermediates, and excipients. Addresses regulatory and quality issues related to cGMP compliance and advocates in dialogue with FDA and other regulatory authorities.
• SOCMA (Society of Chemical Manufacturers & Affiliates)minorOthers · 14 October 2025Supports growth of specialty chemical industry through peer network, industry knowledge, and resources. Veranova has been recognized by SOCMA's Safety Recognition Program in 2023 and 2024.
• MassBiominorOthers · 14 October 2025Massachusetts biotechnology and pharmaceutical industry association with 1,700+ member organizations. Drives innovation by fostering a supportive business environment in Massachusetts.
• DCAT (Drug, Chemical & Associated Technologies Association)minorOthers · 14 October 2025Over 135-year-old not-for-profit business development association for bio/pharmaceutical sector companies. Provides insight into industry trends and best practices through expert-driven education.
• CIA (Chemical Industries Association)minorOthers · 14 October 2025UK's leading trade association representing chemical and pharmaceutical companies. Provides expert advice, shares good practice, and reports on relevant policy developments with 200+ members.
• CEED (Centre for Engineering, Education and Development)minorOthers · 14 October 2025Peer-to-peer best practice-sharing organization for manufacturing, engineering, and technology companies. Pools talents and resources to achieve operational excellence.
• SPAC (Scottish Patient Awareness Council)minorOthers · 14 October 2025Scottish life sciences platform for discussing best practices and sharing patient stories. Collaborates with Scottish Government, Scottish Enterprise, Edinburgh University.
• NutribandminorOEM/ Whitelabel/ Licensing Partner · 14 October 2025Nutriband is a licensed partner of Bitrex, using Veranova's Bitrex technology in their innovative drug delivery systems and devices. Nutriband develops pharmaceutical products from pre-clinical testing through clinical manufacturing.

Scale indicators9 records

Recent moves9 records

Expansion highlights6 records

Broad incumbents

• Lonza Group: Swiss-headquartered global CDMO leader offering mammalian and small molecule API services including HPAPI and ADC capabilities. Comparable as a comprehensive CDMO competitor to pharma/biotech sponsors, though substantially larger and more diversified across biologics, cell/gene therapy, and small molecules.
• Catalent (Novo Holdings): Large diversified CDMO with strong small molecule, biologics, and oral drug product capabilities. Competes with Veranova for outsourced pharmaceutical development and manufacturing programs across both early-phase and commercial supply.
• WuXi AppTec / STA Pharmaceutical: Asia-headquartered large CDMO offering end-to-end small molecule and biologics services. Competes with Veranova on price-sensitive commercial API programs and increasingly on complex modalities.
• Thermo Fisher Scientific (Patheon/CDMO): Pharma services division within Thermo Fisher encompassing API, oral solid dose, sterile fill-finish, and clinical trial material services. Directly comparable as a small molecule API CDMO serving large pharma and biotech sponsors.

Direct peers

• Alcami Corporation: US-based CDMO focused on small molecule API development and manufacturing, including sterile and parenteral capabilities. Comparable as a mid-sized pure-play API CDMO serving pharma and biotech.
• Piramal Pharma Solutions: CDMO with deep expertise in API development and manufacturing including HPAPIs, ADCs, and complex small molecules. Highly comparable service portfolio; notably Dr. Matteo Villain joined Veranova from Piramal, reinforcing direct competitive overlap.
• Carbogen Amcis: Specialist CDMO focused on highly potent and complex APIs including ADC payloads, with strong containment capabilities. Highly comparable to Veranova's HPAPI and ADC linker/payload service offering.
• Cambrex: Small molecule API CDMO with active pharmaceutical ingredient development and manufacturing capabilities across multiple sites. Privately held by Permira; directly comparable as a pure-play small molecule API CDMO competitor.
• Bachem Holding: Swiss-listed specialist CDMO focused on peptide and oligonucleotide (TIDES) manufacturing, the exact segment Veranova entered via the Villain hire. Comparable as a high-purity API manufacturer targeting complex modalities.
• Siegfried Holding: Swiss-listed CDMO specializing in small molecule API manufacturing including controlled substances and HPAPIs. Directly comparable in service offering and customer base; competes on complex chemistry capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/veranova_life
• YouTubeyoutube.com/channel/UCCKA_Py316anGR4_bb0ltPA
• LinkedInlinkedin.com/company/veranovalife

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles17 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Veranova